Method validation and clinical utility of chromogenic factor VIII assay compared to one-stage assay

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 2, 2014, Pages 210-215

  Gouws, Wilmare ^a   Botha, Elsabie ^a   Visser, Adele ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Chromogenic FVIII; Clinical implementation; Clinical utility; Method validation; One stage FVIII

Indexed keywords

CHROMOGENIC SUBSTRATE;

ADULT; ARTICLE; CHILD; CHROMOGENIC FACTOR VIII ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORRELATIONAL STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HEMOPHILIA A; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MALE; ONE STAGE FACTOR VIII ASSAY; PRIORITY JOURNAL; VALIDATION STUDY;

BLOOD CHEMICAL ANALYSIS; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE;

EID: 84894671115     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0910-3     Document Type: Article

References (36)

1. Chandler W, Ferrell C et al (2003) Comparison of three methods for mesauring factor VIII levels in plasma. Am J Clin Pathol 120:34-39
2. Koster T, Blann A et al (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurance of deep-vein thrombosis. Lancet 345(8943):152-155
3. Barrowcliffe T, Raut S et al (2002) Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization and recommendations. Semin Thromb Hemost 28(3):247-256
4. Barrowcliffe T (1984) Methodology of the two-stage assay of Factor VIII (VIII:C). Scand J Haematol 33(Suppl 41):25-38
5. Over J (1984) Methodology of the one-stage assay of factor VIII (VIII:C). Scand J Haematol 33(Suppl 41):13-24
6. Rosen S, Friberger P et al (1986) A new chromogenic assay for determination of human factor VIII:C activity. College of American Pathologists, Skokie
7. Denson K, Biggs R (1976) Laboratory diagnosis, tests of clotting function and their standardization. Lippincott, Oxford
8. Peerlinck K, Jacquemin M (2010) Mild haemophilia: a disease with many faces and many unexpected pitfalls. Haemophilia 16(Suppl 5):100-106
9. Hill N, Deam S et al (2005) Mutation analysis of 51 patients with haemophilia A: report of ten novel mutations an correlation between genotype and clinical phenotype. Haemophilia 11:13-141
10. Keeling D, Sukhu K et al (1999) Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His 1954 - Leu substitutution in the factor VIII A3 domain. Br J Haematol 105:1123-1126
11. Kemball-Cook G, Tuddenham E et al (1998) The factor VIII structure and mutation resource site: HAMSTeRS version 4. Nucleic Acids Res 26:216-219
12. Lyall H, Hill M et al (2008) Tyr346-Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype - is this mild haemophilia A? Haemophilia 14:78-80
13. Pipe S, Saenko E et al (2007) Haemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factro VIIIa. Blood 97:685-697
14. Rudzki Z, Duncan E et al (1996) Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Br J Haematol 94:400-406
15. Schwaab R, Oldenburg J et al (2000) Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694IIe) in a large Danish family. Br J Haematol 109(3):523-528
16. Gilmore R, Harmon S et al (2010) Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy. Haemophilia 16:671-674
17. Mumford A, Laffan M et al (2002) A Tyr346-> Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy. Br J Haematol 118(2):589-594
18. Poulsen A, Pedersen L et al (2009) Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre. Haemophilia 15:285-289
19. ICH (1995) Validation of analytical procedures: text and methodology. The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH, Geneva
20. Collazo V, Alonso C et al (2012) Validation of an automated chromogenic assay of potency of factor VIII in commercial concentrates. Int J Lab Hematol 35(1):38-45
21. White G, Rosendaal F et al (2001) Definitions in hemophilia. recommendations of the scientific subcommittee on FVIII and factor IX of the SCC and ISTH. Thromb Haemost 85:560
22. Begbie M, Notley C et al (2000) The Factor VIII acute phase response requires the participation of NFkappaB and C/EBP. Thromb Haemost 84(2):216-222
23. Noe D, Murphy P et al (1989) Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am J Physiol 257(1):49-56
24. Bjorkman S, Blanchette V et al (2010) Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring. J Thromb Haemost 8(4):730-736
25. Hathaway, W., M. Christian, et al. (1983). "Variant mild haemophilia. Discrepancy in one stage and two stage factor VIII assays." Thromb Haemost (Suppl 50): 357
26. Parquet-Gernez A, Mazurier C et al (1988) Fuctional and immunological assays of FVIII in 133 haemophiliacs - characterization of a subgroup of patients with mild haemohilia A and descrepancy in 1- and 2-stage assays. Thromb Haemost 59:202-206
27. Duncan E, Duncan B et al (1994) Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of paitents with haemophilia A. Br J Haematol 87:846-848
28. Goodeve A, Peake I (2003) The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development. Semin Thromb Hemost 29:23-30
29. Mazurier C, Gaucher C et al (1997) Mutations in the FVIII gene in seven families with haemophilia A. Br J Haematol 96:426-427
30. Roelse, J., R. de-Laaf, et al. (1999). Altered sensitivity towards factor IXa explains assay discrepancies in plasma of haemophilia A patients with a Glu720-> Lys substitution in factor VIII. Thromb Haemost. doi: 10.1111/j.1365-2141.2007.06935.x
31. Goodeve, A., J. Hinks, et al. (2001). Unusual discrepant factor VIII:C assays in haemophilia A patients iwth Tyr346Cys and Glu321Lys FVIII gene mutations. Thromb Haemost. doi: 10.1111/j.1365-2516.2011.02509.x
32. Trossaert M, Boisseau P et al (2011) Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity. J Thromb Haemost 9:524-530
33. European Pharmacopoiea (2010) Assay of human coagulation factor VIII (01/2008:20704) and monograph human coagulation factor VIII (01/2010:0275). E. D. f. t. Q. o. M. HealthCare, Strassbourg
34. Cid A, Calabuig M et al (2008) One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype. Haemophilia 14:1049-1054
35. Plug I, Mauser-Bunchoten E et al (2006) Bleeding in carriers of hemophilia. Blood 108(1):52-56
36. Verbruggen B, Meijer P et al (2008) Diagnosis of factor VIII deficiency. Haemophilia 14(Suppl 3):76-82